Skip to main content
. 2017 Dec 15;9(3):3379–3393. doi: 10.18632/oncotarget.23273

Table 2B. Causes of death by time period after transplant.

MAC RIC
TBF BF TBF BF
Before day 100 Total 14 184 8 157
Infection 4 (29%) 39 (21%) 3 (38%) 20 (13%)
GVHD 4 (29%) 31 (17%) 0 24 (15%)
Original disease 2 (14%) 89 (49%) 3 (38%) 100 (65%)
Cardiac toxicity 0 0 1 (13%) 1 (1%)
Haemorhage 1 (7%) 1 (1%) 0 1 (1%)
Failure/Rejection 0 2 (1.1%) 0 0
VOD 2 (14%) 8 (4%) 0 0
Interstitial Pneumonitis 0 2 1 (13%) 1 (1%)
Second malignancy 0 0 0 0
Other transplantation related 1 (7%) 10 (5%) 0 8 (5%)
Missing 0 2 0 2
From day 100 to 2 years Total 25 274 8 259
Original disease 9 (38%) 141 (54%) 4 (57%) 112 (46%)
GVHD 8 (33%) 59 (23%) 3 (43%) 71 (29%)
Infection 5 (21%) 44 (17%) 0 44 (18%)
Haemorhage 0 0 0 2 (1%)
Failure/Rejection 0 0 0 2 (1%)
VOD 0 0 0 0
Cardiac toxicity 0 1 (1%) 0 0
Interstitial Pneumonitis 0 4 (2% ) 0 2 (1% )
Second malignancy 1 (4% ) 1 (1% ) 0 3 (1% )
Other transplantation related 1 (4% ) 10 (4% ) 0 8 (3% )
Missing 1 14 1 15

Abbreviations: BF, busulfan-fludarabine; GVHD, graft-versus-host disease; MAC, myeloablative conditioning; RIC, reduced-intensity conditioning; TBF, thiotepa-busulfan-fludarabine; VOD, veno-occlusive disease.